Total Payments
$13,327
2024 Payments
$3,477
Companies
31
Transactions
776
Medicare Patients
3,917
Medicare Billing
$271,702
Payment Breakdown by Category
Food & Beverage$12,357 (92.7%)
Education$969.55 (7.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,357 | 761 | 92.7% |
| Education | $969.55 | 15 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,684 | 161 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,713 | 72 | $0 (2024) |
| Janssen Biotech, Inc. | $1,346 | 72 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,195 | 63 | $0 (2024) |
| Lilly USA, LLC | $1,106 | 72 | $0 (2024) |
| Amgen Inc. | $740.42 | 42 | $0 (2024) |
| PFIZER INC. | $633.78 | 72 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $523.98 | 29 | $0 (2024) |
| GENZYME CORPORATION | $514.47 | 26 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $460.51 | 33 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,477 | 201 | ABBVIE INC. ($555.34) |
| 2023 | $3,399 | 221 | Regeneron Healthcare Solutions, Inc. ($527.20) |
| 2022 | $2,524 | 161 | ABBVIE INC. ($513.98) |
| 2021 | $1,964 | 129 | AbbVie Inc. ($514.19) |
| 2020 | $682.54 | 32 | AbbVie Inc. ($160.70) |
| 2019 | $528.83 | 17 | AbbVie, Inc. ($241.90) |
| 2018 | $520.96 | 12 | AbbVie, Inc. ($167.61) |
| 2017 | $230.78 | 3 | Celgene Corporation ($111.62) |
All Payment Transactions
776 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: DERMATOLOGY | ||||||
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $1.18 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.06 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $6.27 | General |
| Category: Immunology | ||||||
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $1.87 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/07/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: ANTIBIOTIC | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.32 | General |
| Category: Immunology | ||||||
| 11/22/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $32.43 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $8.70 | General |
| Category: Immunology | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $0.95 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $2.65 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.76 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.05 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,477 | 2,740 | $657,918 | $105,867 |
| 2022 | 14 | 1,074 | 1,817 | $361,455 | $70,231 |
| 2021 | 11 | 1,114 | 1,815 | $375,758 | $82,275 |
| 2020 | 7 | 252 | 366 | $66,367 | $13,329 |
Total Patients
3,917
Total Services
6,738
Medicare Billing
$271,702
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 384 | 548 | $144,124 | $30,486 | 21.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 153 | 198 | $82,962 | $14,577 | 17.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 254 | 365 | $110,825 | $12,907 | 11.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 123 | 146 | $55,188 | $9,045 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 99 | $36,828 | $8,606 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 111 | 111 | $35,631 | $7,129 | 20.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 25 | 25 | $25,050 | $5,584 | 22.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 187 | 1,034 | $86,856 | $5,054 | 5.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 19 | 29 | $21,295 | $3,628 | 17.0% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $17,787 | $1,840 | 10.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 28 | 41 | $8,405 | $1,523 | 18.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,584 | $1,491 | 19.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 39 | 41 | $6,049 | $1,457 | 24.1% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 17 | 17 | $8,075 | $1,439 | 17.8% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 11 | $7,453 | $589.13 | 7.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 17 | $3,430 | $491.39 | 14.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 23 | $375.59 | $19.10 | 5.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 314 | 424 | $79,932 | $23,340 | 29.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 194 | 253 | $76,818 | $9,040 | 11.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 109 | 125 | $42,698 | $8,529 | 20.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 82 | 89 | $25,528 | $5,889 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 61 | $16,665 | $4,785 | 28.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 82 | 82 | $23,864 | $4,712 | 19.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 16 | 18 | $15,380 | $3,851 | 25.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 130 | 656 | $48,465 | $3,290 | 6.8% |
About Dr. Margaret Maxi, M.D
Dr. Margaret Maxi, M.D is a Dermatology healthcare provider based in Neenah, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2016. The National Provider Identifier (NPI) number assigned to this provider is 1982066239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Margaret Maxi, M.D has received a total of $13,327 in payments from pharmaceutical and medical device companies, with $3,477 received in 2024. These payments were reported across 776 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($12,357).
As a Medicare-enrolled provider, Maxi has provided services to 3,917 Medicare beneficiaries, totaling 6,738 services with total Medicare billing of $271,702. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Neenah, WI
- Active Since 03/25/2016
- Last Updated 02/25/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1982066239
Products in Payments
- DUPIXENT (Biological) $2,124
- SKYRIZI (Biological) $1,354
- TALTZ (Drug) $1,089
- TREMFYA (Drug) $847.86
- Otezla (Drug) $782.25
- EUCRISA (Drug) $545.89
- REMICADE (Biological) $498.41
- Sotyktu (Drug) $443.29
- Humira (Biological) $417.89
- OPZELURA (Drug) $415.77
- HUMIRA (Biological) $337.96
- RINVOQ (Biological) $319.98
- ILUMYA (Biological) $310.82
- VTAMA (Drug) $287.37
- COSENTYX (Drug) $277.56
- Cimzia (Drug) $263.94
- LIBTAYO (Biological) $222.36
- COSENTYX (Biological) $200.40
- Zoryve (Drug) $150.87
- Erivedge (Biological) $146.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.